Personal information

Keywords

hematology

Countries

Spain

Activities

Collapse all

Employment (1)

Hospital Universitari Vall d'Hebron: Barcelona, ES

Principal Researcher (Altres grups de recerca)
Employment
Source: Self-asserted source
Carpio Segura Cecilia del Carmen

Works (18)

Tumor flare with T-cell-engaging bispecific antibodies

Leukemia & Lymphoma
2024-08-23 | Journal article
DOI: 10.1080/10428194.2024.2361100
Contributors: Carmelo Carlo-Stella; Michael J. Dickinson; Gloria Iacoboni; Cecilia Carpio; Natalie Dimier; Martin Weisser; Antonia Kwan; Cristiano Ferlini
Source: check_circle
Crossref

Torque Teno Virus plasma DNA load: a novel prognostic biomarker in CAR-T therapy

Bone Marrow Transplantation
2024-01 | Journal article
DOI: 10.1038/s41409-023-02114-0
Contributors: Ana Benzaquén; Estela Giménez; Gloria Iacoboni; Manuel Guerreiro; Rafael Hernani; Eliseo Albert; Cecilia Carpio; Aitana Balaguer; Ariadna Pérez; Carlos S de la Asunción et al.
Source: check_circle
Crossref

Adenovirus-Induced Hemorrhagic Cystitis After CD19-Targeted Chimeric Antigen Receptor T-Cell Therapy in a Patient with Large B-Cell Lymphoma

Immunotherapy
2023-11 | Journal article
DOI: 10.2217/imt-2023-0111
Contributors: Irene Medina; Cecilia Carpio; Isabel Ruiz-Camps; Adaia Albasanz-Puig; Oriana Lopez-Godino; Juliana Esperalba; Francisco Beas; Mario Sanchez-Salinas; Gloria Iacoboni; Pere Barba
Source: check_circle
Crossref

PET‐based radiomics signature can predict durable responses to CAR T‐cell therapy in patients with large B‐cell lymphoma

eJHaem
2023-11 | Journal article
DOI: 10.1002/jha2.757
Contributors: Marta Ligero; Marc Simó; Cecilia Carpio; Gloria Iacoboni; Maria Balaguer‐Montero; Victor Navarro; Mario Andres Sánchez‐Salinas; Sabela Bobillo; Ana Marín‐Niebla; Josu Iraola‐Truchuelo et al.
Source: check_circle
Crossref

Torque Teno Virus Plasma DNA Load: A Novel Prognostic Biomarker in CAR-T Therapy

2023-05-18 | Preprint
DOI: 10.21203/rs.3.rs-2856348/v1
Contributors: Ana Benzaquén; Estela Giménez; Gloria Iacoboni; Manuel Guerreiro; Rafael Hernani; Eliseo Albert; Cecilia Carpio; Aitana Balaguer-Roselló; Ariadna Perez; Carlos Solano de la Asunción et al.
Source: check_circle
Crossref

Impact of Cytomegalovirus Replication in Patients with Aggressive B Cell Lymphoma Treated with Chimeric Antigen Receptor T Cell Therapy

Transplantation and Cellular Therapy
2022-12 | Journal article
DOI: 10.1016/j.jtct.2022.09.007
Contributors: Ester Márquez-Algaba; Gloria Iacoboni; Berta Pernas; Juliana Esperalba; Ibai Los Arcos; Victor Navarro; Arnau Monforte; Francisco Beas; Adaia Albasanz-Puig; Cecilia Carpio et al.
Source: check_circle
Crossref

Selection process and causes of non-eligibility for CD19 CAR-T cell therapy in patients with relapsed/refractory aggressive B-cell non-Hodgkin lymphoma in a European center

Leukemia & Lymphoma
2021-07-29 | Journal article
DOI: 10.1080/10428194.2021.1913141
Contributors: Cecilia Carpio; Gloria Iacoboni; Guillermo Villacampa; Eva Catalá; Sabela Bobillo; Ana Pérez; Moraima Jiménez; Laura Segura; Mireia Olivé; Anna Farriols et al.
Source: check_circle
Crossref

Biomarkers of response to ibrutinib plus nivolumab in relapsed diffuse large B-cell lymphoma, follicular lymphoma, or Richter's transformation

Translational Oncology
2021-01 | Journal article
DOI: 10.1016/j.tranon.2020.100977
Contributors: Brendan P. Hodkinson; Michael Schaffer; Joshua D. Brody; Wojciech Jurczak; Cecilia Carpio; Dina Ben-Yehuda; Irit Avivi; Ann Forslund; Muhit Özcan; John Alvarez et al.
Source: check_circle
Crossref

Potential Survival Benefit for Patients Receiving Allogeneic Hematopoietic Stem Cell Transplantation after Nivolumab Therapy for Relapse/Refractory Hodgkin Lymphoma: Real-Life Experience in Spain

Biology of Blood and Marrow Transplantation
2020-08 | Journal article
DOI: 10.1016/j.bbmt.2020.02.003
Contributors: Carmen Martínez; Cecilia Carpio; Inmaculada Heras; Eduardo Ríos-Herranz; Joan Buch; Antonio Gutierrez; Samuel Romero; Izaskun Zeberio; Irene García-García; Antonia Rodriguez-Izquierdo et al.
Source: check_circle
Crossref

Avadomide monotherapy in relapsed/refractory DLBCL: Safety, efficacy, and a predictive gene classifier

Blood
2020-01-23 | Journal article
DOI: 10.1182/blood.2019002395
Part of ISSN: 0006-4971
Part of ISSN: 1528-0020
Source: Self-asserted source
Carpio Segura Cecilia del Carmen

Safety and activity of ibrutinib in combination with nivolumab in patients with relapsed non-Hodgkin lymphoma or chronic lymphocytic leukaemia: a phase 1/2a study

The Lancet Haematology
2019-02 | Journal article
DOI: 10.1016/s2352-3026(18)30217-5
Part of ISSN: 2352-3026
Source: Self-asserted source
Carpio Segura Cecilia del Carmen

Promising activity of selinexor in the treatment of a patient with refractory diffuse large B-cell lymphoma and central nervous system involvement

Haematologica
2018-02 | Journal article
DOI: 10.3324/haematol.2017.181636
Part of ISSN: 0390-6078
Part of ISSN: 1592-8721
Source: Self-asserted source
Carpio Segura Cecilia del Carmen

Microenvironment regulates the expression of miR-21 and tumor suppressor genes PTEN, PIAS3 and PDCD4 through ZAP-70 in chronic lymphocytic leukemia

Scientific Reports
2017-12 | Journal article
DOI: 10.1038/s41598-017-12135-7
Part of ISSN: 2045-2322
Source: Self-asserted source
Carpio Segura Cecilia del Carmen

Inhibition of BCR signaling using the Syk inhibitor TAK-659 prevents stroma-mediated signaling in chronic lymphocytic leukemia cells

Oncotarget
2017-01-03 | Journal article
DOI: 10.18632/oncotarget.13557
Part of ISSN: 1949-2553
Source: Self-asserted source
Carpio Segura Cecilia del Carmen

Co-culture of primary CLL cells with bone marrow mesenchymal cells, CD40 ligand and CpG ODN promotes proliferation of chemoresistant CLL cells phenotypically comparable to those proliferating <i> in vivo</i>

Oncotarget
2015-04-10 | Journal article
DOI: 10.18632/oncotarget.2939
Part of ISSN: 1949-2553
Source: Self-asserted source
Carpio Segura Cecilia del Carmen

Targeting the proliferative and chemoresistant compartment in chronic lymphocytic leukemia by inhibiting survivin protein

Leukemia
2014-10 | Journal article
DOI: 10.1038/leu.2014.96
Part of ISSN: 0887-6924
Part of ISSN: 1476-5551
Source: Self-asserted source
Carpio Segura Cecilia del Carmen

ZAP-70 Promotes the Infiltration of Malignant B-Lymphocytes into the Bone Marrow by Enhancing Signaling and Migration after CXCR4 Stimulation

PLoS ONE
2013-12-03 | Journal article
DOI: 10.1371/journal.pone.0081221
Part of ISSN: 1932-6203
Source: Self-asserted source
Carpio Segura Cecilia del Carmen

ZAP-70 enhances migration of malignant B lymphocytes toward CCL21 by inducing CCR7 expression via IgM-ERK1/2 activation

Blood
2011-10-20 | Journal article
DOI: 10.1182/blood-2011-01-333682
Part of ISSN: 0006-4971
Part of ISSN: 1528-0020
Source: Self-asserted source
Carpio Segura Cecilia del Carmen
How many people are using ORCID?